Home / Auditor changes / ANI PHARMACEUTICALS INC
Filed 2026-04-07 路 Form 8-K 路 Accession 0001023024-26-000034 small
Price before filing: $77.2 (2026-04-06 close, split/dividend-adjusted)
Market cap at flag: $1.66B (2026-04-07) 路 Latest: $1.53B (2026-10-16)
| Window | ANIP | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +8.7% | +11.0% | -2.3% | 2026-05-07 |
| 90 days | +10.2% | +14.3% | -4.1% | 2026-07-06 |
| 180 days | -6.0% | +18.2% | -24.2% | 2026-10-05 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 7 insiders sold $4.0M (18 sales)
30 days after: 1 insider sold $39K (1 sale)
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2026-01-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $84.33 | $42K | yes | Form 4 |
| 2026-02-12 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 7,032 | $76.55 | $538K | yes | Form 4 |
| 2026-02-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $76.80 | $38K | yes | Form 4 |
| 2026-02-19 | Davis Krista SVP, CHIEF HR OFFICER | Sale | 2,084 | $77.53 | $162K | yes | Form 4 |
| 2026-02-20 | Davis Krista SVP, CHIEF HR OFFICER | Sale | 1,730 | $77.99 | $135K | yes | Form 4 |
| 2026-02-20 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 5,323 | $78.02 | $415K | yes | Form 4 |
| 2026-03-02 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 417 | $74.00 | $31K | yes | Form 4 |
| 2026-03-03 | Gutwerg Ori SVP, GENERICS | Sale | 2,060 | $76.50 | $158K | no | Form 4 |
| 2026-03-03 | Walsh Patrick D Director | Sale | 6,000 | $74.23 | $445K | no | Form 4 |
| 2026-03-05 | CAREY STEPHEN P. SVP & CFO | Sale | 3,312 | $75.42 | $250K | no | Form 4 |
| 2026-03-05 | CAREY STEPHEN P. SVP & CFO | Sale | 4,000 | $75.56 | $302K | no | Form 4 |
| 2026-03-06 | Davis Krista SVP, CHIEF HR OFFICER | Sale | 1,485 | $75.00 | $111K | yes | Form 4 |
| 2026-03-06 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 2,121 | $74.22 | $157K | yes | Form 4 |
| 2026-03-09 | Davis Krista SVP, CHIEF HR OFFICER | Sale | 5,087 | $74.13 | $377K | yes | Form 4 |
| 2026-03-09 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 3,602 | $74.18 | $267K | yes | Form 4 |
| 2026-03-11 | Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Sale | 4,772 | $74.91 | $357K | no | Form 4 |
| 2026-03-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $72.62 | $36K | yes | Form 4 |
| 2026-03-13 | Mutz Christopher HEAD OF RARE DISEASE | Sale | 3,162 | $71.64 | $227K | yes | Form 4 |
| 2026-04-07: red flag filed | |||||||
| 2026-04-13 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $77.95 | $39K | yes | Form 4 |
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2026-01-07 to 2026-05-07. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"(the "Company") notified EisnerAmper LLP ("EisnerAmper") that EisnerAmper would be dismissed as the Company's independent registered public accounting firm."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: dismissed
Disagreements reported: no
Former auditor: EisnerAmper LLP · New auditor: Ernst & Young LLP
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.